Diagnostic Potential of CD44, CD133, and VDR in Epithelial Ovarian Tumors: Association with Histopathology Parameters
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083729 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ljubiša Jovanović und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Medical Cytology, University Clinical Center of Serbia, dr Koste Todorovića 26, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Ovarian Neoplasms, AC133 Antigen, Receptors, Calcitriol. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technology Development and Innovations of the Republic of Serbia, Ministry of Science, Technological Development and Innovations of the Republic of Serbia.
Abstract (Originalsprache)
Cancer stem cells (CSCs) significantly contribute to heterogeneity, malignancy, and therapy resistance in ovarian cancer. Recent studies emphasize the role of the vitamin D receptor (VDR) in regulating cell differentiation and stemness in various types of cancer. This study aims to determine the expression levels of CD44, CD133, and VDR in epithelial ovarian tumors (EOTs) and to compare these levels across different tumor types, including benign, atypical proliferative tumors, and five types of malignant phenotypes, in order to evaluate their potential as diagnostic tools for malignancy. Tissue samples from 218 patients diagnosed with EOT were analyzed. Clinical and histopathologic parameters were recorded. Quantitative immunohistochemical tissue microarray analysis was used to assess the expression levels of CD44, CD133, and VDR using two different scoring systems. Comparisons were made between benign tumors (n = 45), atypical proliferative tumors (n = 42), and ovarian carcinomas (n = 131), including high-grade serous (HGSC) and non-HGSC subtypes. Ovarian cancer, especially HGSC, showed a significantly higher expression of CD44 and VDR (p < 0.05) compared to atypical proliferative tumors and benign tumors. The expression of CD133 was highest in atypical proliferative tumors (p < 0.05). A moderate positive correlation was found between CD44, CD133, and VDR in all groups, with significant correlations with tumor grade and FIGO stage in ovarian cancer (p < 0.05). The increased expression of CD44 and VDR in aggressive ovarian cancer, along with elevated CD133 levels in atypical proliferative tumors, highlights the complexity of tumor biology. These markers may serve as valuable targets for the diagnosis of ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Medical Cytology, University Clinical Center of Serbia, dr Koste Todorovića 26, 11000 Belgrade, Serbia.
- Department of Cytology, Institute for Biological Research "Siniša Stanković", National Institute of Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.
- Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, dr Subotića 15, 11000 Belgrade, Serbia.
- Laboratory for Molecular Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11000 Belgrade, Serbia.
- Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia, dr Koste Todorovića 26, 11000 Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, dr Subotića 8, 11000 Belgrade, Serbia.
ORCID-Profile: Ljubiša Jovanović, Branka Šošić-Jurjević, Sandra Dragičević, Branko Filipović, Stefan Dugalić, Miroslava Gojnić-Dugalić, Aleksandra Nikolić
Förderung
- Ministry of Science, Technology Development and Innovations of the Republic of Serbia
- Ministry of Science, Technological Development and Innovations of the Republic of Serbia
Zitieren
APA
Jovanović, L., Šošić-Jurjević, B., Ćirković, A., Dragičević, S., Filipović, B., Milenković, S., Dugalić, S., Gojnić-Dugalić, M., & Nikolić, A. (2025). Diagnostic Potential of CD44, CD133, and VDR in Epithelial Ovarian Tumors: Association with Histopathology Parameters. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083729
Vancouver
Jovanović L, Šošić-Jurjević B, Ćirković A, Dragičević S, Filipović B, Milenković S, et al. Diagnostic Potential of CD44, CD133, and VDR in Epithelial Ovarian Tumors: Association with Histopathology Parameters. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083729
BibTeX
@article{Jovanovi2025,
author = {Jovanović, Ljubiša and Šošić-Jurjević, Branka and Ćirković, Anđa and Dragičević, Sandra and Filipović, Branko and Milenković, Svetlana and Dugalić, Stefan and Gojnić-Dugalić, Miroslava and Nikolić, Aleksandra},
title = {Diagnostic Potential of CD44, CD133, and VDR in Epithelial Ovarian Tumors: Association with Histopathology Parameters},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083729}
}
EUVIMED